Summary
Updated Aug 31, 2026
David P. Hochman is Chief Executive Officer and Chairperson, Director of Orchestra BioMed Holdings, Inc. (OBIO). 16 SEC Form 4 filings on record going back to 2024, most recently on 12 June 2026. Most recent open-market trade: bought $19K of OBIO on 2 June 2026. Lifetime open-market purchases: $214K. Historical track record: 4/5 stars across 7 tracked purchases.
Recent Transactions
20Every recent SEC Form 4 transaction David P. Hochman has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★☆ (4/5) |
| Total purchases tracked | 7 |
| Purchases with forward-return data | 7 |
| 30-day win rate | 86% |
| 90-day win rate | 43% |
| Avg 5-day return | +5.19% |
| Avg 30-day return | +5.58% |
| Avg 90-day return | +18.65% |
| Best 30-day return | +10.92% |
Trading Pattern
InsiderAlpha's records for David P. Hochman go back to 2024: 16 primary Form 4 filings, an average of 5.3 per year. The typical open-market purchase is $27K (8 buys totaling $214K). The largest single buy on record is $55K of OBIO in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies David P. Hochman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Darren Sherman - $194K of OBIO open-market activity in the last 12 months
- Eric S. Fain - $83K of OBIO open-market activity in the last 12 months
- Jason Aryeh - $40K of OBIO open-market activity in the last 12 months
- RTW INVESTMENTS, LP - $132 of OBIO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David P. Hochman?
David P. Hochman is a corporate insider, tracked as Chief Executive Officer and Chairperson, Director of Orchestra BioMed Holdings, Inc. (OBIO). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David P. Hochman submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has David P. Hochman been buying or selling stock?
Recorded transactions: 8 open-market purchases ($214K) and 0 open-market sales across all tracked filings.
How accurate is David P. Hochman's historical track record?
Across 7 tracked purchases, David P. Hochman averaged +5.6% avg 30-day return with a 86% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
Where can I see all of David P. Hochman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David P. Hochman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial